About Curia
Curia is a company based in Grafton (United States) founded in 1998 was acquired by Curia in March 2014. It operates as a Professional Services and Managed Services. Curia has completed 1 acquisition, including AF Hauser. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product. Curia operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Grafton, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curia Global, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery are provided.
Generic API manufacturing and catalog services are offered.
Biologics discovery and manufacturing solutions are delivered.
Sterile drug product development services are provided.
Funding Insights of Curia
Detailed funding history for Curia
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Curia
Curia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Curia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug research, development, testing, and consulting services are provided.
|
Locked | Locked | Locked |
Investor details for Curia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curia
Curia has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AF Hauser.
Investment portfolio details for Curia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Distributor of generic pharmaceutical drugs
|
Locked | Locked | 1983 | Locked |
Complete acquisition details for Curia
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Curia
Detailed financials for Curia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curia Comparisons
Peer comparison for Curia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curia
Curia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
Detailed competitors of Curia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curia
Curia was founded in 1998.
Curia is headquartered in Grafton, United States.
John Ratliff is the current CEO of Curia.
Curia is involved in providing comprehensive contract development and manufacturing services for the pharmaceutical and biopharmaceutical industries. Services are offered across small molecules, generic APIs, biologics, and sterile drug products. The company supports clients through drug discovery, development, and manufacturing phases with a global network of facilities in North America, Europe, and India. Advanced technologies and scientific expertise are utilized to ensure flexibility and scalability in delivering solutions. Curia is dedicated to accelerating the delivery of therapies to patients while maintaining high standards of quality and excellence.
Curia's top competitors include Evotec, Crown Bioscience and NIH.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Curia has made 1 acquisition, including AF Hauser.
Curia has 1 investor. Key investors include Curia.